Provider Quick Alert

October 4, 2017
Short-Acting Opioid Limits Begin 12-01-17
Opioid misuse is a significant public health concern. Because QualChoice is committed to ensuring the safety of our members and their communities, we are implementing new Short-Acting Opioid (SAO) limits:
  • Effective 12/01/17, QualChoice will implement limits on the number of Morphine Milligram Equivalents (MME) a member can receive at any given time of a Short-Acting Opioid (SAO) medication (brand or generic)
     
  • There will be separate limits for:
    1. Members who are new to therapy
    2. Members who are existing users of opioids
These limits are consistent with recent guidelines from the Centers for Disease Control and Prevention.  Please Note:   We will first screen the past 360 days of a member's Rx profile for oncology drugs and, if one is found, will not initiate quantity limit.

Stay tuned for additional details as the implementation nears. For questions, call us at  501.228.7111 or  800.235.7111 .
1710 MK 004